BridgeBio Pharma (BBIO) PT Lowered to $80 at Goldman Sachs

May 10, 2021 9:06 AM EDT
Get Alerts BBIO Hot Sheet
Price: $60.34 -4.42%

Rating Summary:
    11 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 11 | New: 50
Trade Now! 
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi lowered the price target on BridgeBio Pharma (NASDAQ: BBIO) to $80.00 (from $92.00) while maintaining a Buy rating.

You May Also Be Interested In

Related Categories

Analyst PT Change